The Health Innovation Network’s National Lipid Optimisation & Familial Hypercholesterolaemia (FH) Programme has delivered huge impact in its goal to reduce the prevalence of cardiovascular disease and its associated health inequalities, according to the programme’s new Impact Report.
The report celebrates the collective achievements of the programme, which has increased the detection of people with FH, improved lipid management outcomes, and driven awareness and action with healthcare professionals and our populations about the importance of cholesterol in cardiovascular risk.
Led by Health Innovation North East and North Cumbria, the programme involved the implementation of NICE endorsed national guidance for lipid management and prevention of cardiovascular disease.
Pete Waddingham, the Health Innovation Network's Net Zero Lead, discusses how we're supporting a Net Zero NHS through innovation, and its potential to reduce demand. We all know climate change contributes to poor health, with air pollution linked to a number of health conditions including cardiovascular disease, respiratory disease and cancer. We also know it’s [...]
Karina Malhotra (pictured on the right) is the Founder and Managing Director of Acumentice - a healthcare improvement consultancy. Karina’s background is in the NHS, with operational leadership roles in NHS Trusts across London. Her product, Evolve Learning, provides targeted learning and development for staff in the NHS. It’s delivered on an e-learning platform, in [...]
At the Health Innovation Network we have always had a dual focus on improving both the health and wealth of the nation and have demonstrated the huge contribution that the health and life sciences industry can make to economic growth. Since 2018, our support to innovators has leveraged £2.6 billion for the UK economy. We're [...]
